Follow-up Care for Breast Cancer Survivors

Kathryn J. Ruddy, Jeph Herrin, Lindsey Sangaralingham, Rachel A. Freedman, Ahmedin Jemal, Tufia C. Haddad, Summer V. Allen, Tina Hieken, Judy C. Boughey, Patricia A. Ganz, Rachel D. Havyer, Nilay D. Shah

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Breast cancer survivorship guidelines recommend at least annual follow-up visits, yet the degree to which this occurs in clinical practice is uncertain. Claims data from a US commercial insurance database (OptumLabs) were used to identify women treated with curative intent surgery for newly diagnosed breast cancer between 2006 and 2014. In 25 035 women, median follow-up was 3 years. In the second year after surgery, 9.6% of the patients did not visit a primary care provider, an oncologist, or a surgeon (guideline-nonadherent). The guideline-nonadherent proportion increased from 7.8% in women diagnosed in 2006 to 12.2% in those diagnosed in 2014 (two-sided Wald P <. 001). During years 2-6, guideline-nonadherence was also associated with older age, nonwhite race, no radiation, no chemotherapy, no endocrine therapy, and increasing time after surgery. There is a substantial and increasing rate of inadequate follow-up among breast cancer survivors. This has the potential to impair outcomes.

Original languageEnglish (US)
Pages (from-to)111-113
Number of pages3
JournalJournal of the National Cancer Institute
Issue number1
StatePublished - Jan 1 2020

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Follow-up Care for Breast Cancer Survivors'. Together they form a unique fingerprint.

Cite this